Literature DB >> 12204489

Task force #1--magnitude of the prevention problem: opportunities and challenges. 33rd Bethesda Conference.

Emelia J Benjamin1, Sidney C Smith, Richard S Cooper, Martha N Hill, Russell V Luepker.   

Abstract

Mesh：

Year:  2002        PMID： 12204489     DOI： 10.1016/s0735-1097(02)02082-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  14 in total

1.  Stress myocardial perfusion imaging by CMR provides strong prognostic value to cardiac events regardless of patient's sex.

Authors:  Otavio R Coelho-Filho; Luciana F Seabra; François-Pierre Mongeon; Shuaib M Abdullah; Sanjeev A Francis; Ron Blankstein; Marcelo F Di Carli; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2011-08

2.  The Unchartered Frontier: Preventive Cardiology Between the Ages of 15 and 35 Years.

Authors:  Holly Gooding; Heather M Johnson
Journal:  Curr Cardiovasc Risk Rep       Date:  2016-08-02

3.  Churches as targets for cardiovascular disease prevention: comparison of genes, nutrition, exercise, wellness and spiritual growth (GoodNEWS) and Dallas County populations.

Authors:  Tiffany M Powell-Wiley; Kamakki Banks-Richard; Elicia Williams-King; Liyue Tong; Colby R Ayers; James A de Lemos; Nora Gimpel; Jenny J Lee; Mark J DeHaven
Journal:  J Public Health (Oxf)       Date:  2012-07-18       Impact factor: 2.341

4.  The GoodNEWS (Genes, Nutrition, Exercise, Wellness, and Spiritual Growth) Trial: a community-based participatory research (CBPR) trial with African-American church congregations for reducing cardiovascular disease risk factors--recruitment, measurement, and randomization.

Authors:  Mark J DeHaven; Maria A Ramos-Roman; Nora Gimpel; JoAnn Carson; James DeLemos; Sue Pickens; Chris Simmons; Tiffany Powell-Wiley; Kamakki Banks-Richard; Kerem Shuval; Julie Duvahl; Julie Duval; Liyue Tong; Natalie Hsieh; Jenny J Lee
Journal:  Contemp Clin Trials       Date:  2011-06-02       Impact factor: 2.226

5.  Analysis of high risk factors and characteristics of coronary artery in premenopausal women with coronary artery disease.

Authors:  Zhijuan Li; Jianxin Cheng; Liping Wang; Peng Yan; Xiangyong Liu; Debao Zhao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Significant association of female gender with lower degree of pathological 99mTc-sestamibi scintigraphy results as well as higher cardiac-related deaths free survival in elderly patients.

Authors:  Jan Bucerius; Alexius Y Joe; Ellen Herder; Holger Brockmann; Michael J Reinhardt; Holger Palmedo; Klaus Tiemann; Hans-Jürgen Biersack
Journal:  Med Klin (Munich)       Date:  2011-01-16

7.  Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.

Authors:  Mark Doyle; Nicole Weinberg; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; Anthon Fuisz; William J Rogers; Edward G Walsh; B Delia Johnson; Barry L Sharaf; Carl J Pepine; Sunil Mankad; Steven E Reis; Diane A Vido; Geetha Rayarao; Vera Bittner; Lindsey Tauxe; Marian B Olson; Sheryl F Kelsey; Robert W W Biederman
Journal:  JACC Cardiovasc Imaging       Date:  2010-10

Review 8.  Women and ischemic heart disease: evolving knowledge.

Authors:  Leslee J Shaw; Raffaelle Bugiardini; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

9.  Evaluating gender differences in prognosis following SPECT myocardial perfusion imaging among patients with diabetes and known or suspected coronary disease in the modern era.

Authors:  Maria Theresa H Santos; Matthew W Parker; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-08-21       Impact factor: 5.952

10.  Cardiovascular risk status and primary prevention in postmenopausal women: the MENOCARD study.

Authors:  Zoltan Vajo; Nandor Acs; Karoly Toth; Elek Dinya; György Paragh; Albert Csaszar
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.